• Same-store sales growth: Mature centers achieved 14% growth driven equally by 7% volume expansion and 7% value growth from advanced technological surgeries, supported by a 25% rise in patient footfalls to 30 lakh.
• Network expansion plans: The company targets adding 60 new centers over the next 12 months, comprising 40 premium surgical centers and 20 micro-market clinics, with Delhi NCR and Haryana serving as key expansion regions.
• Medium-term growth outlook: Management expects to sustain its historical compounding growth rates over the next 3 to 4 years, aiming to scale toward ₹4,500 to ₹5,000 crore in revenue barring major headwinds.
• Payer mix distribution: Cash payments account for roughly 63% of revenues, insurance and TPAs contribute 25% to 27%, and government schemes represent 8% to 9%, with out-of-pocket retail optical sales generating about 13% of total revenue.